ORS 689.802
Prescription of short-acting opioid antagonist

(1)

As used in this section:

(a)

“Opioid” means a natural, synthetic or semisynthetic chemical that interacts with opioid receptors on nerve cells in the body and brain to reduce the intensity of pain signals and feelings of pain.

(b)

“Opioid overdose” means a medical condition that causes depressed consciousness, depressed respiratory function or the impairment of vital bodily functions as a result of ingesting opioids.

(c)

“Short-acting opioid antagonist” means any short-acting drug approved by the United States Food and Drug Administration for the complete or partial reversal of an opioid overdose.

(2)

In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205 (Rules), a pharmacist may prescribe a short-acting opioid antagonist and the necessary medical supplies to administer the short-acting opioid antagonist.

(3)

If a prescription is presented to a pharmacist for dispensing an opiate or opioid in excess of a morphine equivalent dose established by rule by the board, the pharmacist may offer to prescribe and provide, in addition to the prescribed opiate or opioid, a short-acting opioid antagonist and the necessary medical supplies to administer the short-acting opioid antagonist. [Formerly 689.682]

Source: Section 689.802 — Prescription of short-acting opioid antagonist, https://www.­oregonlegislature.­gov/bills_laws/ors/ors689.­html (accessed May 26, 2025).

689.005
Definitions 689.025
Policy 689.035
Short title 689.045
Severability 689.115
Membership 689.135
General powers of board 689.139
State Board of Pharmacy Account 689.145
Enforcement powers of board 689.151
Board control over licensing, standards and discipline 689.153
Continuing authority of board upon lapse, suspension, revocation or voluntary surrender of license or certificate 689.155
Authority of board over medications, drugs, devices and other materials 689.165
Officers 689.175
Compensation of board members and executive director 689.185
Meetings 689.195
Employees 689.205
Rules 689.207
Authority of board to require fingerprints 689.225
License requirement 689.255
Qualifications for licensure by examination 689.265
Qualifications for licensure by reciprocity 689.275
Renewal of licenses 689.285
Continuing education 689.295
Practice of clinical pharmacy 689.305
Registration of drug outlets 689.315
Application 689.325
Required reports 689.335
Certificate required 689.405
Grounds for discipline 689.445
Penalties and reinstatement 689.455
Duty to report suspected violations and prohibited conduct 689.486
When license required 689.490
Board to establish licensing system 689.495
Provision of licensing information 689.497
Report required upon termination of pharmacy technician 689.499
Pharmacy technician specialized education program 689.503
Licensing of pharmaceutical representatives 689.505
Labeling requirements 689.508
Prescription records 689.515
Regulation of generic drugs 689.522
Substitution of biological products for prescribed biological products 689.524
Approval of coverage for biological product 689.525
Out-of-state prescriptions 689.527
Prohibited practices 689.532
Complimentary samples 689.555
Agricultural drugs and certain other substances 689.557
Disposal of marijuana item left at retail drug outlet 689.561
Prescription readers 689.564
Language requirements for prescription drug labels 689.605
Power to dispense drugs from hospital pharmacies, drug rooms and penal institutions 689.615
Display of certificate or license 689.635
Dispensing according to naturopathic formulary 689.645
Vaccines, patient care services, drugs and devices 689.649
Public Health and Pharmacy Formulary Advisory Committee 689.655
Power to administer drugs and devices 689.661
Power to perform tests and examinations related to federally cleared analytes 689.689
Prescription and administration or dispensation of certain contraceptives 689.692
Dispensation of prescription drug containing cannabinoids 689.696
Prescription and dispensation of emergency refills of insulin 689.700
Telepharmacy 689.702
Access to pharmacy electronic database 689.703
Final verification 689.704
Preexposure and post-exposure antiretroviral therapies 689.770
Definitions for ORS 689.770 to 689.780 689.772
Establishment of program 689.774
Rules 689.776
Inspection 689.778
Eligibility 689.780
Immunity 689.800
Opioid overdose 689.802
Prescription of short-acting opioid antagonist 689.804
Administration of short-acting opioid antagonist by certain persons 689.806
Notice of availability of short-acting opioid antagonist 689.808
Short-acting opioid antagonist standing order 689.811
Publicly accessible short-acting opioid antagonist 689.813
Exemption from drug labeling requirements 689.832
Civil penalties 689.854
Civil penalty for violation of ORS 689.515 689.995
Criminal penalties

Current through early 2026

§ 689.802. Prescription of short-acting opioid antagonist's source at oregon​.gov